N-dibenzothiophen-3-yl-N-[4-[9-(4-fluorophenyl)carbazol-2-yl]phenyl]dibenzofuran-4-amine
C48H29FN2OS — CID 168814321
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-dibenzothiophen-3-yl-N-[4-[9-(4-fluorophenyl)carbazol-2-yl]phenyl]dibenzofuran-4-amine
N-dibenzothiophen-3-yl-N-[4-[9-(4-fluorophenyl)carbazol-2-yl]phenyl]dibenzofuran-4-amine (PubChem CID 168814321) has the molecular formula C48H29FN2OS and a molecular weight of 700.84 g/mol. Its IUPAC name is N-dibenzothiophen-3-yl-N-[4-[9-(4-fluorophenyl)carbazol-2-yl]phenyl]dibenzofuran-4-amine.
Molecular Properties
| Compound Name | N-dibenzothiophen-3-yl-N-[4-[9-(4-fluorophenyl)carbazol-2-yl]phenyl]dibenzofuran-4-amine |
|---|---|
| PubChem CID | 168814321 |
| Molecular Formula | C48H29FN2OS |
| Molecular Weight | 700.84 g/mol |
| Exact Mass | 700.20 |
| IUPAC Name | N-dibenzothiophen-3-yl-N-[4-[9-(4-fluorophenyl)carbazol-2-yl]phenyl]dibenzofuran-4-amine |
| SMILES | Fc1ccc(-n2c3ccccc3c3ccc(-c4ccc(N(c5ccc6c(c5)sc5ccccc56)c5cccc6c5oc5ccccc56)cc4)cc32)cc1 |
| InChI | InChI=1S/C48H29FN2OS/c49-32-19-23-34(24-20-32)51-42-12-4-1-8-36(42)37-26-18-31(28-44(37)51)30-16-21-33(22-17-30)50(35-25-27-40-39-10-3-6-15-46(39)53-47(40)29-35)43-13-7-11-41-38-9-2-5-14-45(38)52-48(41)43/h1-29H |
| InChIKey | KNZVEJFRWUVBGE-UHFFFAOYSA-N |
| XLogP | 14.33 |
| TPSA | 21.31 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 53 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 700.84 |
| LogP ≤ 5 | 14.33 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 4 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 168814321 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.